DE
BSX icon

DV Equities’s Boston Scientific BSX Stock Holding History

DV Equities’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$197K Buy
+2,065
New +$202K 0.04% 138

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

DV Equities's BSX Position: Q4 2025 in Review

DV Equities opened a new position in Boston Scientific (BSX) in Q4 2025: 2,065 shares worth $197K. The stake represents 0.04% of the portfolio and ranks #138 among its holdings.

1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • DV Equities held 2,065 shares of Boston Scientific worth $197K as of Q4 2025.
  • Boston Scientific was a new DV Equities position in Q4 2025.
  • Boston Scientific made up 0.04% of DV Equities's portfolio in Q4 2025, its #138 holding.
  • 1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on DV Equities's 13F filing for Q4 2025, filed 17 Feb 2026.